julio_poterico's profile picture. MD. Clinical Geneticist. MSc Precision Cancer Medicine |  Clinical Bioinfomatics (on the way) Precision and Personalized Medicine | Research & Innovation

Julio A. Poterico 🧑🏻‍💻🇵🇪

@julio_poterico

MD. Clinical Geneticist. MSc Precision Cancer Medicine | Clinical Bioinfomatics (on the way) Precision and Personalized Medicine | Research & Innovation

Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

RI2, Research Integrity Risk Index sites.aub.edu.lb/lmeho/ri2/

daforerog's tweet image. RI2, Research Integrity Risk Index

sites.aub.edu.lb/lmeho/ri2/

Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

Systematic review asks: What works? Scoping review asks: What exists? Many researchers confuse the two! --------------------------------------- Learn in more detail in this accredited course: 🔗 systematicreview.razia-aliani.com ---------------------------------------- Here's when a

RaziaAliani's tweet image. Systematic review asks: What works?
Scoping review asks: What exists?
Many researchers confuse the two!

---------------------------------------
Learn in more detail in this accredited course:
🔗 systematicreview.razia-aliani.com
----------------------------------------

Here's when a

Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

Does extreme age inherently mean poor health? New researchanalyzed the biological profile of a supercentenarian and found a fascinating paradox: canonical markers of #aging (like telomere attrition) coexisted with powerful protective mechanisms. This suggests #longevity isn't

KulikovUNIATF's tweet image. Does extreme age inherently mean poor health?

New researchanalyzed the biological profile of a supercentenarian and found a fascinating paradox: canonical markers of #aging (like telomere attrition) coexisted with powerful protective mechanisms. This suggests #longevity isn't

Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

🚨BREAKING: Google just dropped another hit! It's called PaperBanana and it generates publication-ready academic illustrations from just your methodology text. No Figma. No manual design. No illustration skills needed. Here's how it works: A team of AI agents runs behind the

hasantoxr's tweet image. 🚨BREAKING: Google just dropped another hit!

It's called PaperBanana and it generates publication-ready academic illustrations from just your methodology text.

No Figma. No manual design. No illustration skills needed.

Here's how it works:

A team of AI agents runs behind the

Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

Hallmarks of cancer—Then and now, and beyond: Cell cell.com/cell/fulltext/…


Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

Precision oncology and genetic ancestry: The science behind population-based cancer disparities dlvr.it/TKHjzw

Cancer_Cell's tweet image. Precision oncology and genetic ancestry: The science behind population-based cancer disparities dlvr.it/TKHjzw

Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

Global alliances in translational cancer research dlvr.it/TKD9Cd

Cancer_Cell's tweet image. Global alliances in translational cancer research dlvr.it/TKD9Cd

Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

Reporting of molecular test results from cell-free DNA analyses: expert consensus recommendations from the 2023 European Liquid Biopsy Society ctDNA Workshop - eBioMedicine thelancet.com/journals/ebiom…


Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

No other class of anticancer drug comes close to the number of cures that can be attributed to chemotherapy. Yet, our understanding of how it truly works is extremely limited. This perspective on the topic is a must read. Including for ADC enthusiasts. nature.com/articles/s4156…

PTarantinoMD's tweet image. No other class of anticancer drug comes close to the number of cures that can be attributed to chemotherapy.

Yet, our understanding of how it truly works is extremely limited.

This perspective on the topic is a must read.

Including for ADC enthusiasts.

nature.com/articles/s4156…

Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

New online! The genetic basis of human height bit.ly/4crXfl6

NatureRevGenet's tweet image. New online! The genetic basis of human height bit.ly/4crXfl6

Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

Artificial intelligence-based biomarkers for treatment decisions in oncology: Trends in Cancer cell.com/trends/cancer/…


Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

Disrupted sleep and circadian rhythms are deeply intertwined with mental health. They don’t just reflect mental illness—they can drive it. And psychiatric symptoms further disrupt sleep. Restoring circadian health could be a powerful treatment 🧵 1/12

BrandonLuuMD's tweet image. Disrupted sleep and circadian rhythms are deeply intertwined with mental health.

They don’t just reflect mental illness—they can drive it. And psychiatric symptoms further disrupt sleep.

Restoring circadian health could be a powerful treatment 🧵 1/12

Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

The Rare Therapies Launchpad: a pilot program for individualized medicines in the UK. Correspondence from Daniel O’Connor, Julia Vitarello and colleagues @GenomicsEngland @UniofOxford @BostonChildrens Mila’s Miracle Foundation nature.com/articles/s4159…


Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

🔬 The ESMO Tumor-Agnostic Classifier and Screener (ETAC-S) introduces a framework for evaluating molecularly guided therapies beyond tumor type. 💡 Where does Liquid Biopsy fit in? ✅ Enables non-invasive genomic profiling for tumor-agnostic therapies 🩸 ✅ Detects targetable

isliquidbiopsy's tweet image. 🔬 The ESMO Tumor-Agnostic Classifier and Screener (ETAC-S) introduces a framework for evaluating molecularly guided therapies beyond tumor type.

💡 Where does Liquid Biopsy fit in?
✅ Enables non-invasive genomic profiling for tumor-agnostic therapies 🩸

✅ Detects targetable

Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

🚨 ctDNA as a Prognostic Biomarker in Esophagogastric Cancer 🧬🩸 🔍 Key Findings from Lander et al., 2024: ✅ Postoperative ctDNA detection predicts recurrence risk 📊 ✅ Patients with ctDNA+ in MRD window had 6.2x higher recurrence risk ⚠️ ✅ 100% recurrence rate in ctDNA+

isliquidbiopsy's tweet image. 🚨 ctDNA as a Prognostic Biomarker in Esophagogastric Cancer 🧬🩸

🔍 Key Findings from Lander et al., 2024:
✅ Postoperative ctDNA detection predicts recurrence risk 📊
✅ Patients with ctDNA+ in MRD window had 6.2x higher recurrence risk ⚠️
✅ 100% recurrence rate in ctDNA+
isliquidbiopsy's tweet image. 🚨 ctDNA as a Prognostic Biomarker in Esophagogastric Cancer 🧬🩸

🔍 Key Findings from Lander et al., 2024:
✅ Postoperative ctDNA detection predicts recurrence risk 📊
✅ Patients with ctDNA+ in MRD window had 6.2x higher recurrence risk ⚠️
✅ 100% recurrence rate in ctDNA+
isliquidbiopsy's tweet image. 🚨 ctDNA as a Prognostic Biomarker in Esophagogastric Cancer 🧬🩸

🔍 Key Findings from Lander et al., 2024:
✅ Postoperative ctDNA detection predicts recurrence risk 📊
✅ Patients with ctDNA+ in MRD window had 6.2x higher recurrence risk ⚠️
✅ 100% recurrence rate in ctDNA+

Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

Anti-Aging strategy

NutrioSci's tweet image. Anti-Aging strategy

Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

The most quoted paper in Cancer is now published: Cancer Statistics, 2025 acsjournals.onlinelibrary.wiley.com/doi/full/10.33…

DrChoueiri's tweet image. The most quoted paper in Cancer is now published:

Cancer Statistics, 2025

acsjournals.onlinelibrary.wiley.com/doi/full/10.33…
DrChoueiri's tweet image. The most quoted paper in Cancer is now published:

Cancer Statistics, 2025

acsjournals.onlinelibrary.wiley.com/doi/full/10.33…

Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

🚨 #LiquidBiopsy Highlights from SABCS 2024 🚨 Key insights on ctDNA and MRD in breast cancer: 🧬 MRD Monitoring: Early detection of recurrence with ctDNA (ZEST, SURMOUNT, ALIENOR). 🧬 Predictive Biomarkers: ctDNA-driven therapy guidance (PIK3CA, ESR1, AKT pathways). 🧬

isliquidbiopsy's tweet image. 🚨 #LiquidBiopsy Highlights from SABCS 2024 🚨

Key insights on ctDNA and MRD in breast cancer:

🧬 MRD Monitoring: Early detection of recurrence with ctDNA (ZEST, SURMOUNT, ALIENOR).

🧬 Predictive Biomarkers: ctDNA-driven therapy guidance (PIK3CA, ESR1, AKT pathways).

🧬

Julio A. Poterico 🧑🏻‍💻🇵🇪 님이 재게시함

Global health engagement strengthens US security, prosperity and leadership. Correspondence from Benjamin Mason Meier, Muhammad Jawad Noon, Xinshu She & Keith Martin @CUGHnews nature.com/articles/d4159…

NatureMedicine's tweet image. Global health engagement strengthens US security, prosperity and leadership.

Correspondence from Benjamin Mason Meier, Muhammad Jawad Noon, Xinshu She & Keith Martin @CUGHnews

nature.com/articles/d4159…

Loading...

Something went wrong.


Something went wrong.